Low

Step 1: The overall sentiment of the management's discussion is optimistic. The company highlights its performance and growth throughout the filing, stating, "Our primary objectives have remained the same throughout the pandemic: to support the safety of our team members and their families and continue to support patients around the world." This positive outlook indicates confidence in the company's ability to navigate challenges.

Step 2: Relevant numbers and figures in the discussion show a significant increase in net sales, both for the three months ended September 30, 2020, and the nine months ended September 30, 2020. The company achieved 20.1% and 14.4% growth in consolidated net sales, respectively. Additionally, net income has improved significantly, with a $70.0 million increase for the nine months ended September 30, 2020, compared to the same period in 2019.

Step 3: The successful increase in net sales and net income, driven by growth in the Proprietary Products segment and COVID-19 related activities, indicates that the company has performed well in the current quarters. The financial results point towards a positive trajectory with the potential for continued growth.

Based on the optimistic sentiment, strong financial performance, and positive outlook presented in the filing, the company is classified as having a low risk of bankruptcy. The company's ability to adapt and perform well during challenging times, along with the growth in net sales and net income, suggests a stable financial position.